Funding Details
- Awarder
- RSS - feeds.arstechnica.com
- Date Award
- August 02, 2024
- Vertical
- Regenerative Medicine
- Funding URL
- View Funding Page
Company Info
- Founding Year
- None
- Traction
- The research has led to proof-of-concept drug screening tests on the ISS, with plans for further experiments in simulated microgravity conditions on Earth.
- Organizations Involved
- International Space Station, Stanford University
- Founders
- Ngan F. Huang
- Company Description
- The Stanford University research team specializes in regenerative medicine and tissue engineering, focusing on the effects of microgravity on human muscle cells. Their innovative muscle-on-chip systems are designed to study muscle atrophy and aging processes in a microgravity environment, with the goal of developing drugs to counteract muscle loss during space missions.
- Market
- Space Research
- Location
-
Stanford,
CA,
US
- Coinvestors
- None
Links